Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01907269 · ClinicalTrials.gov registry record · NA
A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 2,684
- Enrollment target
NCT01907269: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT01907269 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 2,684 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01907269, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,684 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct a randomized trial of a tailored intervention designed to provide personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and digital video discs (DVDs). The content will be uniquely tailored to each person based on barriers to care, age and race/ethnicity. We will conduct a controlled, cluster-randomized trial of this intervention to determine differences in post-intervention rates of osteoporosis care between two randomization arms. We hypothesize that participants randomized to the intervention arm, compared to those randomized to a control arm, will receive more osteoporosis care at 6 months post-intervention, as evidenced by higher rates of: (H1) Prescription osteoporosis therapies, (H2) Non-prescription therapy with calcium and vitamin D, and (H3) Bone mineral density (BMD) testing.
Primary Outcome
We will assess the number of participants that self-report the initiation of an osteoporosis prescription medication. It will be assessed using a self-completed survey. Osteoporosis prescription medications that will be assessed include: alendronate, calcitonin, denosumab ibandronate, raloxifene, risedronate, teriparatide, and zoledronic acid. We will not include initiation of estrogen hormone therapies as part of the primary outcome.
Interventions
- BEHAVIORAL Video-based Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,684 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-11 |
| Phase | NA |
What the finished NCT01907269 record still lists
NCT01907269 is an interventional study that assigns participants to a tested intervention. Its 2,684 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% higher).
The record links to 0 conditions, and to 1 intervention - of which Video-based Intervention is the first listed.
NCT01907269 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01907269 about?
NCT01907269 is a clinical study titled "A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care". The purpose of this study is to conduct a randomized trial of a tailored intervention designed to provide personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving...
What is the current status of trial NCT01907269?
This trial is currently completed. It is a NA study. The enrollment target is 2,684 participants. The study started on 2013-08. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01907269?
The interventions under investigation include: Video-based Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01907269?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01907269's enrollment target sits among peer trials
2,684 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05111925 · 2,690 participants
Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement
- NCT05471908 · 2,674 participants · NA
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia